![Breakthrough therapy / Chemistry / Pharmaceutical sciences / Carbamates / Pharmacology / Pyrrolidines / Ombitasvir/paritaprevir/ritonavir / Ritonavir / Ombitasvir / AbbVie Inc. / Paritaprevir / Kidney Breakthrough therapy / Chemistry / Pharmaceutical sciences / Carbamates / Pharmacology / Pyrrolidines / Ombitasvir/paritaprevir/ritonavir / Ritonavir / Ombitasvir / AbbVie Inc. / Paritaprevir / Kidney](https://www.pdfsearch.io/img/8995e9a5a1221d4fb6b31deb299730a9.jpg) Date: 2016-08-04 23:27:20Breakthrough therapy Chemistry Pharmaceutical sciences Carbamates Pharmacology Pyrrolidines Ombitasvir/paritaprevir/ritonavir Ritonavir Ombitasvir AbbVie Inc. Paritaprevir Kidney | | Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatioAdd to Reading ListSource URL: www.pmda.go.jpDownload Document from Source Website File Size: 95,95 KBShare Document on Facebook
|